https://www.selleckchem.com/
Thirty-day mortality rates were 12% in the ViV TAVI cohort versus 0% in the redo SAVR cohort (p = .542). Within the first year after hospital discharge, one patient after ViV TAVI had redo surgical intervention. ViV TAVI and redo SAVR lead to excellent functional results in patients with degenerated FSB. Post-procedural early complications must be considered particularly in patients with ViV TAVI because of higher clinical risk profiles. ViV TAVI and redo SAVR lead to excellent functional results in patients with degenerated FSB. Post-procedural early compl
Like
Comment
Share
